India, a key country in the International Diabetes Federation (IDF) South-East Asia region, is grappling with a growing diabetes crisis. Of the 589 million global diabetes cases, 107 million are in this region. By 2050, the regional number is expected to rise to 185 million. India alone has a staggering 89.8 million adult diabetes cases, with a 10.5% adult prevalence rate among its 947 million adult population.
To raise awareness and promote better care, World Diabetes Day is observed every year on November 14. The 2024 theme, “Breaking Barriers, Bridging Gaps,” emphasizes collaborative action to improve diagnosis, treatment, and equal access to care. It also encourages health systems to address care disparities and foster inclusion.
India Continuous Glucose Monitoring Devices Market Report Segmentation
This report forecasts revenue growth at country levels and analyzes the latest industry trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the India CGM devices market report based on product, connectivity, indication and distribution channel:Product Outlook (Revenue, USD Million, 2021-2033)
- Standalone CGM Devices
- Devices
- Consumables (Receivers, Sensors, and Transmitters)
- Integrated CGM-Insulin Pump Systems
Connectivity Outlook (Revenue, USD Million, 2021-2033)
- Bluetooth
- 4G/Cellular
- NFC (Near Field Communication)
Indication Outlook (Revenue, USD Million, 2021-2033)
- Type 1 Diabetes
- Type 2 Diabetes
Distribution Channel Outlook (Revenue, USD Million, 2021-2033)
- Pharmacies
- E-commerce
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
The major companies profiled in this India Continuous Glucose Monitoring Devices market report include:- Abbott Laboratories
- Dexcom Inc.
- Medtronic PLC
- Ascensia Diabetes Care
- Roche Diagnostics India
- Nemaura Medical
- DrStore Healthcare Services India Pvt Ltd
- Ultrahuman
- Actofit
- AmiciCare
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 125 |
Published | August 2025 |
Forecast Period | 2024 - 2033 |
Estimated Market Value ( USD | $ 138.9 Million |
Forecasted Market Value ( USD | $ 672.9 Million |
Compound Annual Growth Rate | 19.1% |
Regions Covered | India |
No. of Companies Mentioned | 10 |